Zosano Pharma (NASDAQ:ZSAN) is scheduled to be releasing its earnings data on Tuesday, February 27th. Analysts expect Zosano Pharma to post earnings of ($0.24) per share for the quarter.
Zosano Pharma (NASDAQ:ZSAN) opened at $4.30 on Tuesday. Zosano Pharma has a 12 month low of $3.61 and a 12 month high of $67.60. The firm has a market cap of $8.47, a P/E ratio of -0.18 and a beta of 1.90.
Separately, ValuEngine raised shares of Zosano Pharma from a “strong sell” rating to a “sell” rating in a research note on Wednesday, February 7th.
In other Zosano Pharma news, Director Kenneth Greathouse acquired 55,000 shares of the company’s stock in a transaction dated Wednesday, December 6th. The stock was acquired at an average cost of $0.61 per share, with a total value of $33,550.00. Following the purchase, the director now directly owns 200,000 shares in the company, valued at approximately $122,000. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 2.83% of the company’s stock.
A hedge fund recently raised its stake in Zosano Pharma stock. Northern Trust Corp boosted its position in Zosano Pharma Corp (NASDAQ:ZSAN) by 591.4% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 79,234 shares of the biotechnology company’s stock after acquiring an additional 67,774 shares during the period. Northern Trust Corp owned about 0.20% of Zosano Pharma worth $112,000 at the end of the most recent reporting period.
WARNING: “Zosano Pharma (ZSAN) Scheduled to Post Quarterly Earnings on Tuesday” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://ledgergazette.com/2018/02/20/zosano-pharma-zsan-scheduled-to-post-quarterly-earnings-on-tuesday.html.
About Zosano Pharma
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma and related companies with MarketBeat.com's FREE daily email newsletter.